Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Prathyaya, Ramesh"'
Autor:
Cory Kosche, Dinesh Jaishankar, Cormac Cosgrove, Prathyaya Ramesh, Suyeon Hong, Lin Li, Rohan S. Shivde, Deven Bhuva, Bethany E. Perez White, Sabah S. Munir, Hui Zhang, Kurt Q. Lu, Jennifer N. Choi, I. Caroline Le Poole
Publikováno v:
JID Innovations, Vol 3, Iss 5, Pp 100190- (2023)
Checkpoint inhibitors treat a variety of tumor types with significant benefits. Unfortunately, these therapies come with diverse adverse events. Skin rash is observed early into treatment and might serve as an indicator of downstream responses to the
Externí odkaz:
https://doaj.org/article/bf60c39b95234552aa2a36ad912185ff
Autor:
Ancy Thomas, Saurav Sumughan, Emilia R. Dellacecca, Rohan S. Shivde, Nicola Lancki, Zhussipbek Mukhatayev, Cristina C. Vaca, Fei Han, Levi Barse, Steven W. Henning, Jesus Zamora-Pineda, Suhail Akhtar, Nikhilesh Gupta, Jasmine O. Zahid, Stephanie R. Zack, Prathyaya Ramesh, Dinesh Jaishankar, Agnes S.Y. Lo, Joel Moss, Maria M. Picken, Thomas N. Darling, Denise M. Scholtens, Daniel F. Dilling, Richard P. Junghans, I. Caroline Le Poole
Publikováno v:
JCI Insight, Vol 6, Iss 22 (2021)
Mutations underlying disease in tuberous sclerosis complex (TSC) give rise to tumors with biallelic mutations in TSC1 or TSC2 and hyperactive mammalian target of rapamycin complex 1 (mTORC1). Benign tumors might exhibit de novo expression of immunoge
Externí odkaz:
https://doaj.org/article/f0d788c1bbd34b7ead95bd619eb9df37
Autor:
Emilia R. Dellacecca, Zhussipbek Mukhatayev, Suhail Akhtar, Levi Barse, Jesus Zamora-Pineda, Dinesh Jaishankar, Fei Han, Nikhilesh Gupta, Ancy Thomas, Thomas N. Darling, Daniel F. Dilling, Steven W. Henning, Saurav Sumughan, Agnes Lo, Cristina C. Vaca, Prathyaya Ramesh, I. Caroline Le Poole, Richard P. Junghans, Maria M. Picken, Joel Moss, Stephanie R. Zack, Denise M. Scholtens, Jasmine O. Zahid, Nicola Lancki, Rohan Shivde
Publikováno v:
JCI Insight
Mutations underlying disease in tuberous sclerosis complex (TSC) give rise to tumors with biallelic mutations in TSC1 or TSC2 and hyperactive mammalian target of rapamycin complex 1 (mTORC1). Benign tumors might exhibit de novo expression of immunoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95be4ecf89201764db103aaec62ab691
https://pubmed.ncbi.nlm.nih.gov/34806651
https://pubmed.ncbi.nlm.nih.gov/34806651
Publikováno v:
Cancers, Vol 13, Iss 821, p 821 (2021)
Cancers
Cancers
Simple Summary Cytokines are molecules that help cells communicate at short range. Often, a single cytokine is measured in patient tissues to understand whether immune cells are actively clearing a tumor. We can learn whether a therapy works, even be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d503fe497b676959a5f4400d6662e9c
https://www.mdpi.com/2072-6694/13/4/821
https://www.mdpi.com/2072-6694/13/4/821
Autor:
Dinesh, Jaishankar, Cormac, Cosgrove, Prathyaya, Ramesh, James, Mahon, Rohan, Shivde, Emilia R, Dellacecca, Shiayin F, Yang, Jeffrey, Mosenson, José A, Guevara-Patiño, I Caroline, Le Poole
Publikováno v:
Cell Stress Chaperones
Developing immunosuppressive therapies for autoimmune diseases comes with a caveat that immunosuppression may promote the risk of developing other conditions or diseases. We have previously shown that biolistic delivery of an expression construct enc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8a9b21e9d9e99f32073e12130f47a76
https://pubmed.ncbi.nlm.nih.gov/34542825
https://pubmed.ncbi.nlm.nih.gov/34542825